Rating History for Myriad Genetics (MYGN) by UBS

More Stocks Rated by UBS | Latest Ratings for MYGN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
9/9/2026 Douglas Schenkel New Coverage Neutral
(N/A)		 3.60
(N/A)		 3.18
(4.28)		 34.59% Details